The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of enzalutamide (ENZA) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) and cardiometabolic comorbidities (CMDs) and/or related concomitant medications (meds): ARCHES post hoc.
 
Arnulf Stenzl
Patents, Royalties, Other Intellectual Property - 2018/6579 Gene-expression signature for subtype and prognostic prediction of renal cell carcinoma; AT00/0001:C-Trap, implantable device to treat urinary incontinence; Patent A290/99 Implantable incontinence device
 
Andrew Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Boundless Bio; Bristol-Myers Squibb; Cytogen; Exelixis; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer; Precede Bio; Sumitomo Pharma Oncology
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); pathos (Inst); Pfizer (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc
 
Daniel Petrylak
Consulting or Advisory Role - Ada Cap; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bicycle Therapeutics; Boehringer Ingelheim France; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Gilead Sciences; Incyte; Infinity Pharmaceuticals; Ipsen; Janssen; Lilly; Merck; Mirati Therapeutics; Monopteros Therapeutics; Pfizer; Pharmacyclics; Regeneron; Roche; Sanofi/Aventis; Seagen; UroGen pharma
Research Funding - Ada Cap; Agensys; Arvinas; Astellas Pharma; AstraZeneca; Bayer; BioXcel Therapeutics; Bristol-Myers Squibb; Clovis Oncology; Daiichi Sankyo; Eisai; Endocyte; Ferring; Genentech; Gilead Sciences; Innocrin Pharma; Lilly; MedImmune; Medivation; Merck; Mirati Therapeutics; Novartis; Pfizer; Progenics; Replimune; Roche; Sanofi Aventis GmbH; Seagen
 
Neal Shore
Stock and Other Ownership Interests - Photocure
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; ImmunityBio; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Nusano; Pfizer; Photocure; PlatformQ Health; Promaxo; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Russell Szmulewitz
Consulting or Advisory Role - Amgen; Bayer; Eisai; Janssen Oncology; Merck; Novartis; Sanofi
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen Oncology (Inst); Janux Therapeutics (Inst); Merck (Inst); Novartis (Inst); Nurix (Inst); Progenics (Inst)
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer
Travel, Accommodations, Expenses - DAVA Oncology
 
Jeffrey Holzbeierlein
Stock and Other Ownership Interests - MoKan Laboratories
Consulting or Advisory Role - Johnson & Johnson; UroGen pharma
Speakers' Bureau - Johnson & Johnson
 
Arnauld Villers
Consulting or Advisory Role - Astellas Pharma; Bayer
Research Funding - Astellas Pharma; Janssen
 
Antonio Alcaraz
Honoraria - Astellas Pharma; Bayer; Ipsen; Janssen; Olympus
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Olympus
 
Boris Alekseev
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Ipsen; Janssen; Merck; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Eisai; Ipsen; Janssen; Merck; Pfizer; Roche
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Eisai; Ipsen; Janssen; Merck; Pfizer; Roche
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Eisai; ICON Clinical Research; Janssen; Merck; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Eisai; Ipsen; Janssen; Merck; Pfizer; Roche
 
Taro Iguchi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo; Eisai; Janssen; Kissei Pharmaceutical; Kyorin; MSD; Nippon Shinyaku; Sanofi; Takeda; Teleflex
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma
 
Francisco Gomez-Veiga
Consulting or Advisory Role - AbbVie; Astellas Pharma; AstraZeneca; Bayer; Ferring; GE Healthcare; GlaxoSmithKline; Ipsen; Janssen; Sanofi
Research Funding - AbbVie; Astellas Pharma; AstraZeneca
 
Ruslan Croitoru
No Relationships to Disclose
 
Mingming Lian
Employment - Astellas Pharma
 
Zhiqiang Xiao
Employment - Astellas Pharma
 
Janet Kim
Employment - Astellas Pharma
 
Matko Kalac
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Guidepoint Global; Seagen
Speakers' Bureau - Kyowa Kirin International
 
Yiyun Tang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Arun Azad
Honoraria - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hinova Pharmaceuticals (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono; Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Hinova Pharmaceuticals; Janssen; Merck Serono; Pfizer; Sanofi; Tolmar